Mei Bin, Yang Xiao, Yang Yue-Yue, Weng Jun-Tao, Cao San-Dong, Yang Rui, Xu Guanghong
Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
Nat Sci Sleep. 2024 Dec 10;16:2009-2020. doi: 10.2147/NSS.S491084. eCollection 2024.
Dexmedetomidine has been reported to improve postoperative sleep quality. However, the underlying mechanism remains unclear. This study aimed to investigate the effect of intraoperative dexmedetomidine infusion on postoperative sleep quality and changes in melatonin secretion in older patients undergoing elective thoracoscopic lung surgery.
A total of 126 older patients were randomly divided into two groups: dexmedetomidine group (Group D), which received continuous dexmedetomidine infusion at 0.3-0.5 µg/(kg·h) combined with propofol during surgery, and propofol group (Group P), which received propofol alone. The primary outcome was the postoperative sleep quality on the first postoperative night, assessed by the Richards-Campbell Sleep Questionnaire (RCSQ). Secondary outcomes included sleep quality scores on the second and third postoperative nights, melatonin concentrations postoperatively, and the incidence of delirium on the first and seventh postoperative days (discharge day).
On the first postoperative night, Group D had a higher sleep quality score compared to Group P (57±11.4 vs 53±10.3; [95% CI, 1.1 to 8.7];P = 0.012), with no difference between the groups on the second and third postoperative nights. There was no statistically significant difference in the preoperative and postoperative night 3 urine 6-SMT concentrations between the two groups (P > 0.05); however, Group D had significantly higher urine 6-SMT concentrations on postoperative nights 1 and 2 compared to Group P (27 (24, 30) vs 21 (17, 24); [95% CI, -8.56 to -4.73]; P = 0.000. 28 (25, 30) vs 26 (21, 27); [95% CI, -4.37 to -1.65]; P = 0.000). There was no significant difference in the incidence of postoperative delirium between the two groups (P=0.65).
Continuous intraoperative infusion of dexmedetomidine can effectively improve sleep quality during the first postoperative night by promoting melatonin secretion over the first two postoperative nights.
据报道,右美托咪定可改善术后睡眠质量。然而,其潜在机制仍不清楚。本研究旨在探讨择期胸腔镜肺手术老年患者术中输注右美托咪定对术后睡眠质量及褪黑素分泌变化的影响。
总共126例老年患者被随机分为两组:右美托咪定组(D组),术中持续输注右美托咪定0.3 - 0.5 μg/(kg·h)联合丙泊酚;丙泊酚组(P组),仅接受丙泊酚。主要结局是术后第一晚的睡眠质量,采用理查兹 - 坎贝尔睡眠问卷(RCSQ)评估。次要结局包括术后第二晚和第三晚的睡眠质量评分、术后褪黑素浓度,以及术后第一天和第七天(出院日)谵妄的发生率。
术后第一晚,D组的睡眠质量评分高于P组(57±11.4对53±10.3;[95%CI,1.1至8.7];P = 0.012),术后第二晚和第三晚两组间无差异。两组术前及术后第3晚尿6 - SMT浓度差异无统计学意义(P > 0.05);然而,与P组相比,D组术后第1晚和第2晚的尿6 - SMT浓度显著更高(27(24,30)对21(17,24);[95%CI, - 8.56至 - 4.73];P = 0.000。28(25,30)对26(21,27);[95%CI, - 4.37至 - 1.65];P = 0.000)。两组术后谵妄发生率差异无统计学意义(P = 0.65)。
术中持续输注右美托咪定可通过在术后头两晚促进褪黑素分泌,有效改善术后第一晚的睡眠质量。